LiuSRenJHongZ. Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn’s disease: a prospective cohort study. Nutr Clin Pract. 2013;28(1):120-127.
2.
ClarkSF. Iron deficiency anemia. Nutr Clin Pract. 2008;23(2):128-141.
3.
GabayCKushnerI. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-454.
4.
SpeeckaertMMSpeeckaertRDelangheJR. Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci. 2010;47(5-6):213-228.
5.
BeguinY. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta. 2003;329(1-2):9-22.
6.
MarkovićMMajkić-SinghNSubotaV. Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease. Scand J Clin Lab Invest. 2005;65(7):571-576.
7.
MengRZhuDBiYYangDWangY. Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice. PLoS One. 2013;8(1):e53557.
